Literature DB >> 25783507

Peritoneal carcinomatosis in primary ovarian cancer staging: comparison between MDCT, MRI, and 18F-FDG PET/CT.

Sabine Schmidt1, Reto Antoine Meuli, Chahin Achtari, John Olivier Prior.   

Abstract

PURPOSE: The aim of this study was to compare multidetector CT (MDCT), MRI, and FDG PET/CT imaging for the detection of peritoneal carcinomatosis (PC) in ovarian cancer. PATIENTS AND METHODS: Fifteen women with ovarian cancer and suspected PC underwent MDCT, MRI, and FDG PET/CT, shortly before surgery. Nine abdominopelvic regions were defined according to the peritoneal cancer index. We applied lesion size scores on MDCT and MR and measured FDG PET/CT standard uptake. We blindly read MDCT, MR, and PET/CT before joint review and comparison with histopathology. Receiver operating characteristics analysis was performed.
RESULTS: Ten women had PC (67%). Altogether, 135 abdominopelvic sites were compared. Multidetector CT, MRI, and FDG PET/CT had a sensitivity of 96%, 98%, and 95%, and specificity was 92%, 84%, and 96%, respectively. Corresponding receiver operating characteristics area was 0.94, 0.90, and 0.96, respectively, without any significant differences between them (P = 0.12). FDG PET/CT detected supradiaphragmatic disease in 3 women (20%) not seen by MDCT or MRI.
CONCLUSIONS: Although MRI had the highest sensitivity and FDG PET/CT had the highest specificity, no significant differences were found between the 3 techniques. Thus, MDCT, as the fastest, most economical, and most widely available modality, is the examination of choice, if a stand-alone technique is required. If inconclusive, PET/CT or MRI may offer additional insights. Whole-body FDG PET/CT may be more accurate for supradiaphragmatic metastatic extension.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25783507     DOI: 10.1097/RLU.0000000000000768

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN: 0363-9762            Impact factor:   7.794


  14 in total

Review 1.  MRI in medical practice and its future use in radiation oncology. Resume of XXV GOCO Congress (Montpellier) 2017.

Authors:  Xavier Druet; Estrella Acosta Sanchez; Ken Soleakhena; Anne Laprie; Jordi Sáez; Stéphanie Nougaret; Olivier Riou; Elodie Rigal; Laura Kibranian; Miguel Palacios; Ismael Membrive
Journal:  Rep Pract Oncol Radiother       Date:  2019-06-05

2.  Selection Criteria for Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy With Special Emphasis on Laparoscopy as an Efficient Tool.

Authors:  Miklos Acs; Aydin Dadras; Sebastian Blaj; Hubert Leebmann; Pompiliu Piso
Journal:  In Vivo       Date:  2022 May-Jun       Impact factor: 2.406

3.  18F-FDG-PET/CT based total metabolic tumor volume change during neoadjuvant chemotherapy predicts outcome in advanced epithelial ovarian cancer.

Authors:  Tuulia Vallius; Johanna Hynninen; Jukka Kemppainen; Victor Alves; Kari Auranen; Jaakko Matomäki; Sinikka Oksa; Johanna Virtanen; Seija Grénman; Annika Auranen; Marko Seppänen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-02-23       Impact factor: 9.236

Review 4.  Systematic Review on the Accuracy of Positron Emission Tomography/Computed Tomography and Positron Emission Tomography/Magnetic Resonance Imaging in the Management of Ovarian Cancer: Is Functional Information Really Needed?

Authors:  Subapriya Suppiah; Wing Liong Chang; Hasyma Abu Hassan; Chalermrat Kaewput; Andi Anggeriana Andi Asri; Fathinul Fikri Ahmad Saad; Abdul Jalil Nordin; Sobhan Vinjamuri
Journal:  World J Nucl Med       Date:  2017 Jul-Sep

5.  Comparison between multi-slice spiral CT and magnetic resonance imaging in the diagnosis of peritoneal metastasis in primary ovarian carcinoma.

Authors:  Hong-Lei Guo; Ling He; Yan-Cui Zhu; Kun Wu; Feng Yuan
Journal:  Onco Targets Ther       Date:  2018-02-28       Impact factor: 4.147

6.  Performance of pre-treatment ¹⁸F-fluorodeoxyglucose positron emission tomography/computed tomography for detecting metastasis in ovarian cancer: a systematic review and meta-analysis.

Authors:  Sangwon Han; Sungmin Woo; Chong Hyun Suh; Jong Jin Lee
Journal:  J Gynecol Oncol       Date:  2018-11       Impact factor: 4.401

7.  Comparison of diagnostic values between CA125 combined with CA199 and ultrasound combined with CT in ovarian cancer.

Authors:  Bingcheng Guo; Wei Lian; Shuai Liu; Yingchun Cao; Jianhua Liu
Journal:  Oncol Lett       Date:  2019-04-18       Impact factor: 2.967

8.  Correlation of surgeon radiology assessment with laparoscopic disease site scoring in patients with advanced ovarian cancer.

Authors:  Nicole D Fleming; Shannon N Westin; Larissa A Meyer; Aaron Shafer; Jose Alejandro Rauh-Hain; Michaela Onstad; Lauren Cobb; Michael Bevers; Bryan M Fellman; Jennifer Burzawa; Priya Bhosale; Behrouz Zand; Amir Jazaeri; Charles Levenback; Robert L Coleman; Pamela T Soliman; Anil K Sood
Journal:  Int J Gynecol Cancer       Date:  2020-11-05       Impact factor: 3.437

Review 9.  Update on Imaging of Ovarian Cancer.

Authors:  Rosemarie Forstner; Matthias Meissnitzer; Teresa Margarida Cunha
Journal:  Curr Radiol Rep       Date:  2016-04-09

Review 10.  Research Progress of MicroRNA in Early Detection of Ovarian Cancer.

Authors:  Ze-Hua Wang; Cong-Jian Xu
Journal:  Chin Med J (Engl)       Date:  2015-12-20       Impact factor: 2.628

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.